Fermenta Biotech Limited (BOM:506414)

India flag India · Delayed Price · Currency is INR
266.40
-0.75 (-0.28%)
At close: May 13, 2025
63.19%
Market Cap 8.92B
Revenue (ttm) 4.27B
Net Income (ttm) 355.32M
Shares Out 29.43M
EPS (ttm) 12.26
PE Ratio 24.72
Forward PE n/a
Dividend 1.25 (0.41%)
Ex-Dividend Date Aug 6, 2024
Volume 19,650
Average Volume 16,327
Open 269.00
Previous Close 267.15
Day's Range 266.00 - 269.00
52-Week Range 145.00 - 449.00
Beta -0.09
RSI 63.96
Earnings Date May 30, 2025

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, enzymes in India, Europe, the United States, and internationally. The company engages in the pharmaceutical formulations and environmental solutions; rents and sales properties; and sports and health awareness/education activities. It offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder used in applications, such as pharmaceuticals, dietary and nutritional supplements, fe... [Read more]

Industry Pharmaceutical Preparations
Founded 1951
Employees 558
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506414
Full Company Profile

Financial Performance

In 2023, Fermenta Biotech's revenue was 3.36 billion, a decrease of -4.08% compared to the previous year's 3.50 billion. Losses were -230.60 million, -54.85% less than in 2022.

Financial Statements

News

There is no news available yet.